Cellia Science

Cellia Science

Point-of-Care Hematology

Founded 2021

Fayetteville, United States 2 employees Debt Financing Total: $300.00K Health Care, Medical Devices

Cellia Science is a United States-based startup that aims to revolutionize the field of hematology with its innovative approach to blood cell assays. The company's slogan, "Point-of-Care Hematology," reflects its commitment to bringing rapid and accurate blood cell testing from the confines of the lab to the convenience of the clinic. By leveraging advanced technology, Cellia Science seeks to provide healthcare professionals with the tools they need to make timely and informed decisions for their patients. With a focus on accessibility and efficiency, Cellia Science's mission aligns with the growing demand for point-of-care diagnostics in the healthcare industry. By enabling quicker diagnosis and treatment, the startup has the potential to significantly impact patient care outcomes. As the company continues to develop and refine its offerings, it may attract interest from venture capital firms aiming to support groundbreaking advancements in medical technology. As the startup landscape evolves, investors may keep a close eye on Cellia Science for potential opportunities. With its disruptive potential and focus on addressing critical healthcare needs, the company could emerge as an intriguing prospect for venture capital funding. As the startup's journey unfolds, it will be important to monitor any developments in funding or partnerships to gauge its trajectory within the rapidly changing healthcare technology space.

Funding Stage	Amount	Investors	Lead Investors	Date
Debt Financing	$50.00K	-		26 May 2023
Seed Round	$250.00K	-		10 Nov 2022

Funding Stage

Amount

Investors

Lead Investors

Date

Debt Financing

$50.00K

26 May 2023

Seed Round

$250.00K

10 Nov 2022

FAQ About Cellia Science

Point-of-Care Hematology

Cellia Science was founded in 2021.

Cellia Science is headquartered in Fayetteville, United States.

Cellia Science operates in Health Care and Medical Devices. Its work centres on Point-of-Care, Hematology, Rapid Assays and Blood Cell Analysis.

Cellia Science has approximately 2 employees.

Cellia Science has completed 2 funding rounds, raising a total of $300.00K. The latest funding stage is Debt Financing.

Top alternatives and competitors to Cellia Science include Scopio Labs, Aksense, NanoSpot.ai, Sight Diagnostics, Ceribell │ AI-Powered Point-of-Care EEG. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Cellia Science and Scopio Labs are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Cellia Science

Funding Rounds & Investors (2)

Cellia Science Alternatives & Competitors

FAQ About Cellia Science